December 17, 2024 Maria Dranishnikova Easy-to-prepare food manufacturer Mama’s Creations sinking after third-quarter earnings
December 16, 2024 Maria Dranishnikova Royce looks at three innovators in the payments processing industry
December 13, 2024 Maria Dranishnikova Barchart.com highlights two Wall Street ‘strong buys’ from the Russell 2000
December 12, 2024 Maria Dranishnikova Piper Sandler sees the Russell 2000 outperforming the S&P 500 in 2025
December 12, 2024 Maria Dranishnikova Lightwave Logic shares plunge to record low following management shake-up
December 11, 2024 Maria Dranishnikova Zacks sees 222% upside in weight-loss market innovator Lexaria Bioscience
December 10, 2024 Maria Dranishnikova Barron’s spotlights six S&P 600 stocks set to keep rallying in 2025
December 9, 2024 Maria Dranishnikova Small-cap maker of cancer tests VolitionRx jumps after direct offering
December 9, 2024 Maria Dranishnikova Air taxi company Archer Aviation surges on news of agreement in UAE
December 6, 2024 Maria Dranishnikova WSJ notes biggest gainers in the small-cap S&P 600 since Trump victory
December 6, 2024 Maria Dranishnikova How small-cap Inuvo is rescuing the $200 billion advertising market amid cookie clampdown
December 5, 2024 Maria Dranishnikova Space exploration company Intuitive Machines slides after share offer with 26% discount
December 5, 2024 Maria Dranishnikova Fintech IDT Corporation gains on strong fiscal first-quarter financials
December 4, 2024 Maria Dranishnikova Zacks SCR reiterates 400% upside call on Nurexone Biologic for risk-tolerant investors
December 4, 2024 Maria Dranishnikova ‘Patriotic marketplace’ PublicSquare jumps 270% after Trump son joins board
December 3, 2024 Maria Dranishnikova Archer Aviation shares plunge following Stellantis CEO resignation
December 3, 2024 Maria Dranishnikova Freedom Broker downgrades tow truck maker Miller Industries to ‘hold’
December 2, 2024 Maria Dranishnikova Shares of gold miner Contango ORE plummet amid rising costs at Alaskan mine
December 2, 2024 Viktoriya Sirota Applied Therapeutics plummets 76% after FDA declines to approve drug
November 29, 2024 Maria Dranishnikova Zacks sees 400% upside for MediciNova amid incoming damages from Sanofi/Novartis dispute